demonstrated that CCM3 mutations lead to robust Rho‐associated protein kinase (ROCK) activity in murine and human CCM vasculature and increase brain vascular permeability in humans with CCM3 mutation. This evidence concerns the gene PDCD10 and cerebral cavernous malformation.